Glenmark Pharmaceuticals to raise debt up to $200 million

Glenmark Pharmaceuticals on Saturday said its shareholders have approved a proposal to raise up to $200 million (about ₹1,413 crore) through issuance

 
– The Hindu – Industry

• Share on Facebook
• Tweet it
• Pin it
• Share it
• Email